What question did this study set out to answer?

To review the pathophysiology, classification, and emerging preventative and therapeutic strategies for hepatorenal syndrome in patients with advanced liver disease.

December 1, 2001HepatologyOpen Access

New challenge of hepatorenal syndrome: Prevention and treatment

View Full Paper

Ask AI

Bookmark

Authors

FWF. Lennie WongCity Of Hope National Medical Center LBLaurence M. BlendisBoston University

Discussion

Member takes

Implication

Review highlights pathogenic mechanisms and emerging nonsurgical therapies in cirrhotic patients, suggesting improved classification will optimize prevention and treatment.

Key Points

To review the pathophysiology, classification, and emerging preventative and therapeutic strategies for hepatorenal syndrome in patients with advanced liver disease.
Synthesized evidence on hemodynamic mechanisms involving portal hypertension, splanchnic vasodilation, and secondary renal failure.
Evaluated nonsurgical interventions, including vasoconstrictor and colloid volume therapy, portovenous shunting, and dialysis modalities.
Sinusoidal portal hypertension and severe hepatic decompensation trigger splanchnic vasodilation and effective hypovolemia, resulting in compensatory renal vasoconstriction.
Reversal of renal failure is achievable nonsurgically through combined splanchnic vasoconstrictors and colloid expansion or transjugular intrahepatic portosystemic shunts.
Differentiating acute type 1 hepatorenal syndrome—which carries nearly 100% mortality—from insidious type 2 disease clarifies precipitating triggers and guides therapeutic selection.

Cite This Study

Wong et al. (2001) studied this question.

synapsesocial.com/papers/6a8233e980b3939dcdca3814 https://doi.org/10.1053/jhep.2001.29200

View Full Paper

Ask AI

Bookmark

Implication

Review highlights pathogenic mechanisms and emerging nonsurgical therapies in cirrhotic patients, suggesting improved classification will optimize prevention and treatment.

New challenge of hepatorenal syndrome: Prevention and treatment

Discussion

Member takes

Implication

Key Points

Cite This Study

New challenge of hepatorenal syndrome: Prevention and treatment

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider